Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(18%)
Results Posted
20%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
3
27%
Ph phase_2
1
9%
Ph phase_3
1
9%
Ph not_applicable
2
18%
Ph early_phase_1
2
18%
Ph phase_1
2
18%

Phase Distribution

4

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
2(18.2%)
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Not yet recruiting2
Recruiting2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (18.2%)
Phase 12 (18.2%)
Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 43 (27.3%)
N/A2 (18.2%)

Trials by Status

not_yet_recruiting218%
recruiting218%
terminated19%
unknown19%
completed545%

Recent Activity

2 active trials
Showing 5 of 11
recruitingphase_1

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

NCT06834126
recruitingphase_1

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

NCT05136846
not_yet_recruitingnot_applicable

Papaverine and Sublingual Microcirculation in Septic Shock

NCT07657741
completedphase_4

IV PAPAVERINE Prior to Propess for Labor Induction

NCT06550232
not_yet_recruitingnot_applicable

Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction

NCT06547437
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06834126Phase 1

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

Recruiting
NCT05136846Phase 1

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

Recruiting
NCT07657741Not Applicable

Papaverine and Sublingual Microcirculation in Septic Shock

Not Yet Recruiting
NCT06550232Phase 4

IV PAPAVERINE Prior to Propess for Labor Induction

Completed
NCT06547437Not Applicable

Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction

Not Yet Recruiting
NCT03894904Phase 4

Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients

Completed
NCT04162834Phase 4

Effect of Papaverine on Renal Artery Blood Flow Volume

Completed
NCT03064282Early Phase 1

Prostatic Hyperplasia Treatment and Cancer Prevention

Unknown
NCT04030663Early Phase 1

The Effect of Periradial Injection of Papaverine Versus Nitroglycerine on Radial Artery Diameter

Completed
NCT02711241Phase 3

Optimal Analgesia in Acute Gastroenteritis

Terminated
NCT00080808Phase 2

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11